EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Establishment of a semi-continuous nano-production line using the Microfluidizer® technology for the fabrication of lipid-based nanoparticles part 1: Screening of critical parameters and design of experiment optimization studies

Christina Glader, Ramona Jeitler, Yan Wang, Carolin Tetyczka, Manuel Zettl, Matthias Schlömer, Philippe Caisse, Steve Mesite, Svea Stephan, Vanessa Bourgeaux, Eva Roblegg

European Journal of Pharmaceutical Sciences · 2024-12 · 203 · 106928

DOI: 10.1016/j.ejps.2024.106928 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutical Sciences, 2024-12. Verfasst von Christina Glader und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, Graz 8010, Austria. Electronic address: christina.glader@rcpe.at. Hauptthemen laut MEDLINE: Nanoparticles, Particle Size, Lipids. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: FFG, BMDW, BMK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesParticle SizeLipidsTechnology, Pharmaceutical

Stichwörter der Autor:innen

Lipid-based nanoparticlesOrganic solvent-free manufacturingQuality by designSemi-continuous top-down nano-production

Substanzen

Lipids

Autor:innen und Institutionen

  • Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, Graz 8010, Austria. Electronic address: christina.glader@rcpe.at.
  • University of Graz, Institute of Pharmaceutical Sciences, Pharmaceutical Technology & Biopharmacy, Universitätsplatz 1, Graz 8010, Austria. Electronic address: ramona.jeitler@uni-graz.at.
  • InProcess-LSP, Kloosterstraat 9, Oss 5349 AB, The Netherlands. Electronic address: y.wang@inprocess-lsp.com.
  • Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, Graz 8010, Austria. Electronic address: carolin.tetyczka@rcpe.at.
  • Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, Graz 8010, Austria. Electronic address: manuel.zettl@rcpe.at.
  • Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, Graz 8010, Austria. Electronic address: matthias.schloemer@rcpe.at.

Förderung

  • FFG
  • BMDW
  • BMK
  • SFG
  • Karl-Franzens-Universität Graz
  • Land Steiermark

Zitieren

APA

Glader, C., Jeitler, R., Wang, Y., Tetyczka, C., Zettl, M., Schlömer, M., Caisse, P., Mesite, S., Stephan, S., Bourgeaux, V., & Roblegg, E. (2024). Establishment of a semi-continuous nano-production line using the Microfluidizer® technology for the fabrication of lipid-based nanoparticles part 1: Screening of critical parameters and design of experiment optimization studies. European Journal of Pharmaceutical Sciences, 203, 106928. https://doi.org/10.1016/j.ejps.2024.106928

Vancouver

Glader C, Jeitler R, Wang Y, Tetyczka C, Zettl M, Schlömer M, et al. Establishment of a semi-continuous nano-production line using the Microfluidizer® technology for the fabrication of lipid-based nanoparticles part 1: Screening of critical parameters and design of experiment optimization studies. European Journal of Pharmaceutical Sciences. 2024;203:106928. doi:10.1016/j.ejps.2024.106928

BibTeX
@article{Glader2024,
  author = {Glader, Christina and Jeitler, Ramona and Wang, Yan and Tetyczka, Carolin and Zettl, Manuel and Schlömer, Matthias and Caisse, Philippe and Mesite, Steve and Stephan, Svea and Bourgeaux, Vanessa and Roblegg, Eva},
  title = {Establishment of a semi-continuous nano-production line using the Microfluidizer® technology for the fabrication of lipid-based nanoparticles part 1: Screening of critical parameters and design of experiment optimization studies},
  journal = {European Journal of Pharmaceutical Sciences},
  year = {2024},
  volume = {203},
  pages = {106928},
  doi = {10.1016/j.ejps.2024.106928}
}
Kostenlos starten →